No, 1 Glass of Red Wine a Day Isn't 'Fine'. Here's Why.

The patient across from me was a 46-year-old advertising executive. Fit, lean, runs marathons. Her blood pressure was creeping up, her ApoB had drifted higher, her fasting glucose was borderline. She drank, by her account, "just one glass of red wine with dinner, for the heart."

She is not unusual. I have this conversation at least twice a week.

The idea that moderate alcohol is good for your heart is one of the most durable pieces of popular health advice of the last 30 years. It appeared in newspapers, on wine labels, in cardiology lectures, and in your grandmother's dinner-party wisdom. It is also, by the best current evidence, wrong. Not partially wrong. Largely wrong, driven by methodological flaws in the original studies, and overturned by a generation of newer research including Mendelian randomisation and careful control for abstainer bias.

In 2023, the World Health Organization stated the position as plainly as a health body ever does: when it comes to alcohol consumption, there is no safe amount that does not affect health.

Let me walk you through why, and what to do about it if you enjoy wine.

The J-Curve and Why It Looked Real

For decades, observational studies consistently showed that light-to-moderate drinkers had lower rates of cardiovascular disease and all-cause mortality than non-drinkers. Plotted on a graph, mortality fell, then rose, then rose sharply, shaped like the letter J.

The explanation offered was that small amounts of alcohol raised HDL cholesterol, reduced platelet aggregation, and improved endothelial function. The French Paradox (France eats butter and cheese but has less heart disease) was often attributed to red wine.

There were two major problems with this interpretation.

First, the "non-drinker" reference group was contaminated. Most studies lumped lifetime abstainers together with former drinkers (who had often quit because of illness, alcoholism, or medical advice). When later studies separated these groups, the "benefit" of moderate drinking shrank dramatically or disappeared entirely. This is called the sick quitter bias, and it was formally quantified by Naimi and colleagues in 2017.

Second, moderate drinkers tend to be healthier in ways that have nothing to do with alcohol. They are wealthier, better educated, eat better, exercise more, and have more stable social lives. These are all strong protective factors that the original studies did not adequately control for.

The 2023 Turning Point: The Anderson Analysis

In 2023, Anderson and colleagues published a systematic review and dose-response meta-analysis in The Lancet Public Health. They applied modern statistical corrections, using only the studies that had clean lifetime-abstainer reference groups or that adjusted for known confounders. The J-curve flattened sharply.

For cardiovascular disease specifically, there was no statistically significant protective effect below about 25 g of alcohol per day (more than two standard drinks), and the confidence interval crossed unity at low doses. For all-cause mortality, a modest apparent benefit at very low consumption was consistent with residual confounding rather than true causation.

A large 2023 JAMA Network Open meta-analysis by Zhao and colleagues, pooling 107 cohort studies (4.8 million participants), reached similar conclusions: low-volume drinkers showed no net mortality benefit when the analysis properly accounted for abstainer bias.

Mendelian randomisation studies, which use genetic variants that predict alcohol intake to mimic a randomised trial, have now largely confirmed this. Biddinger and colleagues published in JAMA Network Open in 2022, analysing 371,463 UK Biobank participants, and found that even light alcohol consumption was associated with increased cardiovascular disease risk, with a nearly linear dose-response.

Put simply: the J-curve was a statistical artefact. The actual curve starts rising as soon as you start drinking.

The Cancer Problem

This is the part most people still don't know.

Alcohol (specifically ethanol and its metabolite acetaldehyde) has been classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC) since 1988. Group 1 means "carcinogenic to humans," the same category as tobacco, asbestos, and ionising radiation.

Alcohol causes at least seven cancers with well-established evidence: oral cavity, pharynx, larynx, oesophagus, liver, colorectum, and female breast. There is no threshold below which the risk disappears. The 2023 WHO / Lancet Public Health position was specific: evidence does not indicate the existence of a particular threshold at which the carcinogenic effects of alcohol start to manifest in the human body.

For breast cancer in particular, the increased risk is detectable at very low levels of drinking. A large 2009 Million Women Study, and subsequent pooled analyses, have shown that each additional 10 g of alcohol per day (roughly one standard drink) increases the risk of breast cancer by around 7 to 12 percent. At one glass per day, the absolute risk increase is small in any one year but meaningful over a lifetime, especially on top of other risk factors.

The WHO statement was blunt on this point: there are no studies that would demonstrate that the potential beneficial effects of light and moderate drinking on cardiovascular diseases outweigh the cancer risk associated with these same levels of alcohol consumption for individual consumers.

The Special Case of Asian Populations

This is not just a Western issue, and for Singaporeans it may matter more.

About 36 percent of East Asians carry a variant of the aldehyde dehydrogenase 2 gene (ALDH2*2) that impairs the breakdown of acetaldehyde, the toxic intermediate in alcohol metabolism. People with this variant flush, feel ill, and have elevated acetaldehyde exposure when they drink, even moderately.

This is sometimes dismissed as just a cosmetic nuisance. It is not. Carriers of ALDH2*2 who drink alcohol have a substantially higher risk of oesophageal squamous cell carcinoma, up to 6- to 10-fold higher in some analyses, and increased risk of head and neck cancers. The 2019 Brooks and colleagues review in Alcoholism: Clinical and Experimental Research remains a clear summary. A 2017 Circulation paper also linked ALDH2*2 with worse cardiovascular outcomes in Asian populations.

In practical terms: if you flush when you drink, your risk profile is materially worse than a non-flushing Caucasian drinking the same amount. The old Western "moderate drinking" guidelines were never validated in Asian genomes.

Alcohol and Longevity Endpoints Beyond Cancer

Even a single glass of wine acutely disrupts sleep architecture (see my recent sleep article), lowers heart rate variability the next day, raises blood pressure modestly, impairs recovery from exercise, and reduces the quality of the gut microbiome.

Chronic moderate drinking is associated with fatty liver (found on FibroScan in many moderate drinkers who don't realise they have it), increased risk of atrial fibrillation (even one drink a day in the Holiday Heart literature), brain atrophy on MRI, and accelerated biological ageing by DNA methylation clocks. None of these outcomes support the idea that "a glass a day is fine."

"But What About the Polyphenols in Red Wine?"

This is the sophisticated counter-argument. Red wine contains resveratrol, anthocyanins, catechins, quercetin, and other polyphenols with documented cardiovascular benefits (improved endothelial function, blood pressure reduction, anti-inflammatory effects). So, the argument goes, surely a glass of red wine gives you the net benefit of polyphenols minus the cost of alcohol?

Here is the good news: the polyphenols are real. Here is the better news: you don't need the alcohol to get them.

Chiva-Blanch and colleagues have produced some of the cleanest data on this. In a series of randomised crossover trials in the early 2010s, they compared red wine, dealcoholised red wine (same polyphenol content, no alcohol), and gin (alcohol, no polyphenols) in the same participants. Their 2012 study in Circulation Research found that dealcoholised red wine significantly reduced systolic and diastolic blood pressure, while regular red wine did not. The polyphenols did the work. The alcohol did not help, and arguably cancelled the benefit.

Follow-up studies from the same group showed that dealcoholised red wine produced improvements in endothelial function, anti-inflammatory markers (IL-6, TNF-alpha), HDL cholesterol, and gut microbiome diversity, while regular red wine produced either smaller or no improvement in the same markers.

The polyphenolic benefits of red wine, in other words, are attributable to the polyphenols, not the ethanol. You can get them from non-alcoholic wine. You can also get them from red grapes, berries, olives, olive oil, tea, coffee, dark chocolate, and a varied Mediterranean-style diet.

What About Resveratrol Supplements?

Resveratrol got enormous hype in the 2000s, largely on the back of animal studies showing lifespan extension. Human trials have been, frankly, disappointing. A 2014 study in JAMA Internal Medicine by Semba and colleagues tracked resveratrol metabolites in older community-dwelling adults and found no association with inflammation, cardiovascular disease, cancer, or all-cause mortality. Randomised trials of resveratrol supplementation have shown small or inconsistent effects on glucose, lipids, or blood pressure.

You are probably better off eating berries than taking a resveratrol capsule.

The Singapore Context

The Singapore Ministry of Health's 2021 guidelines recommend that men drink no more than 2 standard drinks per day and women no more than 1, with at least 2 alcohol-free days per week. These are harm-reduction guidelines, not endorsements.

In clinical practice, I now tell patients: the most evidence-based recommendation today is zero drinks for health reasons, and as little as possible for pleasure reasons, with the understanding that less is always better. If you currently drink, you don't need to quit tomorrow or feel guilty about a glass at your anniversary dinner. But you should stop thinking of that glass as a health behaviour. It isn't.

A Practical Playbook

1. If You Don't Drink, Don't Start

This is the single cleanest recommendation in the 2023 WHO statement. There is no health reason to begin.

2. If You Do Drink, Aim Lower Than You Currently Do

Less is better. There is no lower threshold below which alcohol is truly neutral. The risk curve is essentially linear from zero.

3. Try Non-Alcoholic Alternatives

The non-alcoholic drinks category in Singapore has matured dramatically. Dealcoholised wine (Torres Natureo, Pierre Chavin, Freixenet 0%), non-alcoholic gin and tonics, kombucha, and sparkling water with a twist of citrus all provide the ritual and social element of a drink without the ethanol. For the polyphenol-minded, dealcoholised red wine is a genuinely evidence-based swap.

4. Screen Your Liver

If you drink regularly, a FibroScan or a fasting blood panel (ALT, AST, GGT, fasting insulin) is a cheap way to see what your liver actually looks like under the hood. Many "moderate" drinkers have early fatty liver. The scan takes 10 minutes and gives you your CAP and kPa score.

5. Know Your Genotype

If you flush when drinking (ALDH2*2), your risk profile is materially worse. Even lower levels of drinking, or ideally none, is a more defensible personal position than "moderate is fine."

6. Replace the Ritual, Not Just the Drink

For most people, the glass of wine is not pharmacology. It is the pause at the end of the day, the social anchor, the marker of "now I am off work." If you simply cut the drink and leave the pause unreplaced, you will miss the pause. Replace the ritual. A walk with your partner, a cup of herbal tea, a book, a proper dinner without a screen. The ritual is the real thing.

The Bottom Line

The evidence has moved. What was true medical consensus in 2005 is simply no longer supportable in 2026. The J-curve was an artefact. Alcohol is a Group 1 carcinogen at every dose. Moderate drinking is associated with small but real increases in breast, oesophageal, colorectal, oral and liver cancers, plus atrial fibrillation, sleep disruption, and worse cardiometabolic markers.

If you love the taste of red wine, drink it occasionally and consciously, and spend the rest of the week on dealcoholised versions or good tea. You'll get the polyphenols, the ritual, and a longer, healthier life.

The glass of red wine is not saving your heart. It is quietly raising your cancer risk. And that conversation needs to happen in more clinic rooms, not fewer.

References

1. World Health Organization. No level of alcohol consumption is safe for our health. January 2023. URL: who.int/europe/news
2. Anderson BO, Berdzuli N, Ilbawi A, et al. Health and cancer risks associated with low levels of alcohol consumption. The Lancet Public Health. 2023;8(1):e6-e7. DOI: 10.1016/S2468-2667(22)00317-6
3. Zhao J, Stockwell T, Naimi T, Churchill S, Clay J, Sherk A. Association Between Daily Alcohol Intake and Risk of All-Cause Mortality: A Systematic Review and Meta-analyses. JAMA Network Open. 2023;6(3):e236185. DOI: 10.1001/jamanetworkopen.2023.6185
4. Biddinger KJ, Emdin CA, Haas ME, et al. Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease. JAMA Network Open. 2022;5(3):e223849. DOI: 10.1001/jamanetworkopen.2022.3849
5. Naimi TS, Stockwell T, Zhao J, et al. Selection biases in observational studies affect associations between "moderate" alcohol consumption and mortality. Addiction. 2017;112(2):207-214. DOI: 10.1111/add.13451
6. Chiva-Blanch G, Urpi-Sarda M, Ros E, et al. Dealcoholized red wine decreases blood pressure in patients at high cardiovascular risk. Circulation Research. 2012;111(8):1065-1068. DOI: 10.1161/CIRCRESAHA.112.275636
7. Chiva-Blanch G, Arranz S, Lamuela-Raventos RM, Estruch R. Effects of Wine, Alcohol and Polyphenols on Cardiovascular Disease Risk Factors: Evidences from Human Studies. Alcohol and Alcoholism. 2013;48(3):270-277. DOI: 10.1093/alcalc/agt007
8. International Agency for Research on Cancer. Alcohol Consumption and Ethyl Carbamate. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 96. Lyon: IARC; 2010.
9. Brooks PJ, Enoch MA, Goldman D, Li TK, Yokoyama A. The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLOS Medicine. 2009;6(3):e1000050. DOI: 10.1371/journal.pmed.1000050
10. Semba RD, Ferrucci L, Bartali B, et al. Resveratrol levels and all-cause mortality in older community-dwelling adults. JAMA Internal Medicine. 2014;174(7):1077-1084. DOI: 10.1001/jamainternmed.2014.1582
11. GBD 2020 Alcohol Collaborators. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. The Lancet. 2022;400(10347):185-235. DOI: 10.1016/S0140-6736(22)00847-9
12. Ministry of Health Singapore. Guidelines on alcohol consumption. Singapore: MOH HealthHub; 2023.